India’s equity market has entered a phase where valuation dispersion matters almost as much as headline index valuations. The Nifty 50 is trading around the low-20s on earnings, while recent market commentary has put the Nifty Midcap and Smallcap indices at roughly 33x and 32x earnings, respectively. That creates a wide gap between the valuations of established large companies and businesses where investors are paying for future growth.
This premium is being supported by several factors. Domestic equity flows remain strong, with equity mutual funds receiving Rs.29,329 crore in August 2026 and SIP contributions reaching Rs.32,297 crore, according to AMFI data reported by Reuters. Mid-cap and small-cap funds accounted for a significant part of the inflows, while large-cap funds recorded outflows.
At the same time, foreign investors have remained sellers. In the 30 days to September 21, FII cash selling stood at about Rs.17,663 crore, while DIIs bought approximately Rs.62,915 crore. The result is a market where domestic liquidity continues to support companies with strong growth narratives even as foreign investors remain more selective.
That backdrop helps explain why companies such as Unimech Aerospace, Aditya Infotech, Aether Industries and Avenue Supermarts can command P/E multiples between roughly 80x and 120x. The important question is therefore not simply, Why are these stocks so expensive. It is what future earnings are investors already paying for.
| Company | Approx. P/E | Recent revenue growth | Core growth proposition |
| Unimech Aerospace | ~117.79x | 70.90% | Aerospace, precision manufacturing and new capacity |
| Aditya Infotech | ~91.74x | 89.50% | CP PLUS market share, localisation and capacity |
| Aether Industries | ~99.54x | ~27% | CEM/CRAMS and new manufacturing platforms |
| Avenue Supermarts | ~81.70x | ~15% | Store expansion and long-duration retail compounding |
1. Unimech Aerospace: Paying for the Next Manufacturing Platform
Unimech has one of the highest valuations in the group, at roughly 117.79x earnings. Its Q1 FY27 numbers provide some context for why investors are looking beyond the current earnings base. Revenue rose 70.9% YoY to Rs.107.6 crore, EBITDA increased 98% to Rs.39.3 crore and PAT increased 45.7% to Rs.27.9 crore. EBITDA margin reached 36.5%.
More important than the quarterly numbers, however, is what management is building around them. The consolidated order book stood at approximately Rs.280 crore as of June 30, including Rs.87 crore of nuclear orders. Management said the confirmed order book consists of purchase orders, while the broader pipeline is larger because it includes forecast business and programmes still progressing through qualification.
The company also completed 165 first-article inspections during the quarter and began engaging with six additional prospective customers. Management’s strategy is to increase the contribution from recurring precision components and flying parts rather than remain predominantly a tooling business. That distinction is critical to the valuation.
The market is not necessarily assigning a 117.79x multiple to Unimech’s current Rs.108 crore quarterly revenue. It is attempting to value the business that could emerge after customer qualifications, capacity expansion, the Hobel Bellows acquisition and the transition towards recurring precision manufacturing. The company has also signed a five-year supply agreement with FACC for aerospace components, while management continues to discuss additional programmes with aerospace and engine Tier-1 customers.
The valuation therefore depends on several linked factors: customer qualifications, order conversion, recurring production, capacity utilisation, revenue growth and earnings growth.
The risk is that this process takes time. A Rs.280 crore confirmed order book does not translate into Rs.280 crore of annual revenue immediately. Management indicated that much of the tooling order book is consumed relatively quickly, precision components cover roughly six months, while a substantial portion of the nuclear order book is scheduled for H2 and beyond.
This means the market is capitalising not just confirmed orders, but also the probability of future programme conversions. What needs to deliver: qualification rates, order conversion, Hobel integration, capacity utilisation and, ultimately, ROCE as the company invests in expansion.
2. Aditya Infotech: The Valuation Depends on Growth Remaining Unusually High
Aditya Infotech is perhaps the clearest example of a stock where extraordinary recent growth has created the foundation for an extraordinary valuation.Q1 FY27 revenue reached Rs.1,402 crore, up 89.5% YoY. EBITDA increased to Rs.208 crore and EBITDA margin reached 14.8%, while reported PAT rose 332.5% to Rs.142.2 crore.
Management has retained FY27 revenue guidance of Rs.6,000–6,500 crore and EBITDA margin guidance of 14–15%. The company is also targeting approximately double its current manufacturing capacity over three years.
The strategic proposition is broader than just CCTV demand. CP PLUS contributed approximately 87% of revenue, while IP products represented 79% of its CP PLUS portfolio. Management cited a 43.3% share of India’s video-surveillance market for FY26 and is expanding into higher-end enterprise products, IoT and other adjacent categories.
Localisation is another part of the thesis. The company currently sources a substantial proportion of components such as semiconductors and passive electronics from Taiwan and China, while targeting higher domestic sourcing. It is also expanding backward integration into products such as enclosures, PCBs and lenses.
This gives the market several potential earnings levers. The 91.74x valuation also creates a much higher expectations burden. The Q1 PAT increase should not be extrapolated directly. Post-IPO deleveraging reduced finance costs materially, while the company has also said that the benefit from low-cost inventory has been exhausted and component costs remain elevated. Management is responding through price increases, with gradual pass-through intended to protect margins.
Therefore, the crucial question is not whether Aditya Infotech can grow. It clearly has. The question is whether growth can remain sufficiently high for long enough to support a valuation that already discounts several years of strong earnings expansion.
What needs to deliver: revenue growth, sustainable 14–15% EBITDA margins, market-share retention, capacity utilisation and successful localisation without materially damaging volumes.
3. Aether Industries: The Market Is Paying for a Better Business Mix
Aether’s valuation is interesting because its thesis isn’t simply about higher revenue. It is about what percentage of that revenue comes from higher-value manufacturing relationships.
Q1 FY27 revenue increased approximately 27% YoY to Rs.327 crore, while EBITDA increased 31% to Rs.103 crore and PAT increased 33% to Rs.63 crore. The most important management target is the expansion of CEM and CRAMS.
Management said these businesses currently account for about 60% of Q1 revenue and are targeted to reach 70% or more over the coming years. LSM products, meanwhile, are expected to represent only about 35% of revenue in the longer term. This matters because CEM and CRAMS provide Aether with greater exposure to customer-specific manufacturing programmes rather than relying entirely on individual products.
Aether is also investing heavily to support this transition. Site 5 is being developed through a phased programme, with total investment estimated at approximately Rs.2,200–2,300 crore and Phase 2 associated with FY30. Management has also maintained an asset-turn ambition of around 1.5–1.75x for the mature Site 5 investment.
At the same time, Aether is adding new products and customers. Management reported new marquee clients, customer audits and commercialisation of new products, while semiconductor-related materials and the Dow collaboration provide additional long-term optionality.
This is why Aether’s 99.54x P/E cannot be analysed simply against its current 27% revenue growth. The market is effectively paying for a higher CEM/CRAMS mix, larger customer programmes, new capacity, higher utilisation, sustained margins and higher earnings.
The biggest valuation test will be whether the large capital programme generates sufficient returns. Aether’s own Site 5 target of 1.5–1.75x asset turnover provides a useful metric for investors to monitor.
What needs to deliver: CEM/CRAMS moving towards 70%+, Site 5 utilisation, new product commercialisation, margin durability and returns on the Rs.2,200–2,300 crore investment programme.
4. Avenue Supermarts: The Premium Is for Duration
Avenue Supermarts is perhaps the most revealing company in this comparison because its valuation is around 81.70x despite substantially slower near-term growth than the other three. Q1 FY27 revenue grew 15%, EBITDA increased 24% and PAT increased 11%. The company ended the quarter with 503 stores and approximately 20.7 million sq ft of retail area.
Like-for-like growth, however, moderated to 5.5%, compared with 7.1% a year earlier. Large metro stores were broadly flat, while non-metro locations continued to grow. This creates a completely different valuation equation.
Avenue Supermarts stands apart from the previous three companies as a substantially larger and more mature retail business. While its high valuation remains comparable, it operates at a vastly different scale with an established physical network of over 500 stores. Investors must evaluate its growth trajectory through the lens of steady expansion and like-for-like sales rather than early-stage hypergrowth.
DMart’s premium does not depend on revenue growth. It depends on the belief that the company can keep adding stores for a very long time while maintaining attractive economics across the network. That makes store duration more important than quarterly growth.
The company had 503 stores at the end of Q1 FY27, meaning the future earnings opportunity is partly represented by stores that have not yet been built. The challenge is that the existing store base is already showing signs of maturity in some locations. Like-for-like growth of 5.5% is significantly below the rate required to justify the valuation on existing stores alone.
Therefore, the valuation depends heavily on new stores, mature-store productivity, purchasing scale and operating discipline. What needs to deliver: store additions, same-store sales, revenue per square foot, store-level economics and the ability to expand outside mature metropolitan markets.
What These Four Valuations Tell Us About India
The four companies demonstrate why simply calling India’s market expensive can be misleading. They are expensive for different reasons.The broader market backdrop does, however, make the expectations issue increasingly important.
Kotak Institutional Equities recently argued that many mid- and small-cap stocks were beginning to look expensive even though India’s underlying economic momentum remained strong. The firm pointed to expected Nifty earnings growth of roughly 17–17.5% in FY27, while highlighting the valuation gap between large caps and parts of the mid- and small-cap universe.
Other market participants have made the opposite argument: Emkay Investment Managers has noted that headline index P/E ratios can obscure significant stock-level differences and that earnings growth in mid- and small-caps can justify some of the premium.
This disagreement is important. The question is not whether India deserves a premium. The question is how much growth that premium already assumes. What Does an 80–120x P/E Actually Require? This is where the valuation becomes easier to understand. Suppose a company trades at 90x earnings today. If its share price remains unchanged, the P/E after five years would be approximately:
| EPS CAGR for 5 years | EPS multiple vs today | P/E after 5 years at unchanged price |
| 10% | 1.61x | 56x |
| 15% | 2.01x | 45x |
| 20% | 2.49x | 36x |
| 25% | 3.05x | 30x |
| 30% | 3.71x | 24x |
This shows the central problem with premium valuations. Even 30% annual EPS growth for five years only takes a 90x P/E down to roughly 24x if the share price does not rise. That does not mean a 90x stock cannot generate returns. It means that earnings have to grow exceptionally quickly before the valuation begins to normalise.
For a 117.79x stock such as Unimech, the requirement is even more demanding. At 30% EPS CAGR for five years, a 120x starting P/E would still be around 32x if the share price remained unchanged. This is why the valuation debate is ultimately about time.
The market can justify a very high multiple when the earnings runway is long enough. But the longer the valuation runs ahead of current earnings, the more sensitive the stock becomes to a slowdown in growth, weaker margins, delayed capacity utilisation or lower returns on new capital.